TCL Archive FDA examining endpoints for approval of cancer therapies, potential departure from survival as the gold standard, Oncology Division Director Richard Pazdur says in interview. November 7, 2003
TCL Archive In Brief: Increased Output Can Hold Down High Let Cost, Kligerman says; No More Groups On The Block March 18, 1977
TCL Archive NCI Programs: Klausner Plans 20-25% Increase In Funding For Cooperative Groups November 6, 1998
